Back to search
FDAFDA · Food and drugs·Recall number D-0153-2017

Fentanyl Citrate Injection, USP, 100 mcg Fentanyl/ 2mL, Single Dose, 50 mcg/mL, Rx only, Hospira, Inc., Lake Forest IL 60045, NDC 0409-4093-32

Published November 30, 2016 · Recall initiated: November 1, 2016

Summary

FDA records drug Class II recall D-0153-2017, published November 30, 2016 and initiated November 1, 2016. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 797,800 ampules; Lot: Lot #5 9277EV, 60028EV, 6008EV, Exp 11/1/17. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: Complaints of broken tips on the ampules.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Hospira Inc.
Distributor
Nationwide
Lot
Lot #5 9277EV, 60028EV, 6008EV, Exp 11/1/17
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Fentanyl Citrate Injection, USP, 100 mcg Fentanyl/ 2mL, Single Dose, 50 mcg/mL, Rx only, Hospira, Inc., Lake Forest IL 60045, NDC 0409-4093-32 recalled?

Yes. FDA published recall D-0153-2017 on November 30, 2016. Reported hazard: Lack of Assurance of Sterility: Complaints of broken tips on the ampules.

What should I do if I have this product?

Voluntary: Firm initiated · Letter